ChemoMetec (Denmark) Today
| CHEMM Stock | DKK 287.60 10.00 3.36% |
Performance0 of 100
| Odds Of DistressLess than 10
|
ChemoMetec is trading at 287.60 as of the 19th of April 2024, a -3.36% down since the beginning of the trading day. The stock's open price was 297.6. ChemoMetec has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for ChemoMetec AS are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.
ChemoMetec AS engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company was founded in 1997 and is headquartered in Allerd, Denmark. ChemoMetec operates under Medical Equipment classification in Denmark and is traded on Copenhagen Stock Exchange. The company has 17.4 M outstanding shares. More on ChemoMetec AS
Moving against ChemoMetec Stock
| 0.41 | MAERSK-A | AP Mller | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
ChemoMetec Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. ChemoMetec's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding ChemoMetec or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chief Executive Officer | Steen SoendergaardLarsen |
| Business Concentration | Health Care, Life Sciences Tools & Services, Scientific & Technical Instruments, Technology (View all Sectors) |
ChemoMetec AS (CHEMM) is traded on Copenhagen Exchange in Denmark and employs 162 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 8.48 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ChemoMetec's market, we take the total number of its shares issued and multiply it by ChemoMetec's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. ChemoMetec AS operates under Life Sciences Tools & Services sector and is part of Health Care industry. The entity has 17.4 M outstanding shares.
ChemoMetec AS has accumulated about 209.02 M in cash with 176.86 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.01.
Check ChemoMetec Probability Of Bankruptcy
Ownership AllocationChemoMetec AS retains a total of 17.4 Million outstanding shares. Over half of ChemoMetec's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in ChemoMetec. Please watch out for any change in the institutional holdings of ChemoMetec AS as this could mean something significant has changed or is about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check ChemoMetec Ownership Details
ChemoMetec Stock Price Odds Analysis
What are ChemoMetec's target price odds to finish over the current price? Based on a normal probability distribution, the odds of ChemoMetec jumping above the current price in 90 days from now is about 98.0%. The ChemoMetec AS probability density function shows the probability of ChemoMetec stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon the stock has a beta coefficient of 1.9394 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, ChemoMetec will likely underperform. Additionally, chemoMetec AS has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of ChemoMetec to move above the current price in 90 days from now is about 98.0 (This ChemoMetec AS probability density function shows the probability of ChemoMetec Stock to fall within a particular range of prices over 90 days) .
ChemoMetec AS Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. ChemoMetec market risk premium is the additional return an investor will receive from holding ChemoMetec long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in ChemoMetec. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although ChemoMetec's alpha and beta are two of the key measurements used to evaluate ChemoMetec's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.04 | |||
| Standard Deviation | 5.34 | |||
| Variance | 28.54 | |||
| Risk Adjusted Performance | (0.02) |
ChemoMetec Stock Against Markets
Picking the right benchmark for ChemoMetec stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in ChemoMetec stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for ChemoMetec is critical whether you are bullish or bearish towards ChemoMetec AS at a given time. Please also check how ChemoMetec's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in ChemoMetec without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Aroon Oscillator Now
Aroon OscillatorAnalyze current equity momentum using Aroon Oscillator and other momentum ratios |
| All Next | Launch Module |
ChemoMetec Corporate Management
Elected by the shareholders, the ChemoMetec's board of directors comprises two types of representatives: ChemoMetec inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ChemoMetec. The board's role is to monitor ChemoMetec's management team and ensure that shareholders' interests are well served. ChemoMetec's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ChemoMetec's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Christian Berg | Product Manager | Profile | |
| Kurt Nielsen | Production and Procurement Manager | Profile | |
| Michael Packert | Head of Production | Profile | |
| Kristine Faerch | Director | Profile |
How to buy ChemoMetec Stock?
Before investing in ChemoMetec, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in ChemoMetec. To buy ChemoMetec stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of ChemoMetec. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase ChemoMetec stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located ChemoMetec AS stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased ChemoMetec AS stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as ChemoMetec AS, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in ChemoMetec AS?
The danger of trading ChemoMetec AS is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of ChemoMetec is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than ChemoMetec. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile ChemoMetec AS is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ChemoMetec AS. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for ChemoMetec Stock analysis
When running ChemoMetec's price analysis, check to measure ChemoMetec's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ChemoMetec is operating at the current time. Most of ChemoMetec's value examination focuses on studying past and present price action to predict the probability of ChemoMetec's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ChemoMetec's price. Additionally, you may evaluate how the addition of ChemoMetec to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |